Vendor description
This vendor hasn't published their own description yet. It will appear here once they claim this profile and add it from their dashboard.
At a glance
- Biopharma company that creates subsidiary Vants focused on specific therapeutic areas. Provides clinical development capabilities through its platform…
- Coverage: Global · Phase I–IV
- Therapeutic focus: Oncology, Immunology, Neurology, Rare diseases and 1 more
- Scale: Medium,Large,Global
Company fit
Best suited for
Clinical development platforms,Therapeutic-area-focused drug development,Data analytics (Datavant)
Study fit
Unique model combining biopharma development with technology platforms for clinical trials.
Core strengths
- Innovative Vant model
- Datavant data platform
- Therapeutic depth
Considerations
- Drug developer first,vendor second
- Not a traditional CRO model
Key facts
- Category
- Specialist CRO
- Geography
- Global
- Service model
- Full-service + FSP
- Vendor type
- Full-service
- HQ
- United States
Publications
Reviewed vendor articles, separate from independent ratings.
Browse the publications library